Browsing by Subject "Antifungal agents"

Now showing items 1-3 of 3

    • In vitro activity of isavuconazole against clinically isolated yeasts from Chile 
      Álvarez Duarte, Eduardo; Salas Duguet, Valentina (Springer, 2020)
      Isavuconazole is the last antifungal agent approved by the FDA and available for treatment of fungal infections. In the present study, the in vitro activity of isavuconazole against several yeasts was investigated. Two ...
    • New record of Scedosporium dehoogii from Chile: Phylogeny and susceptibility profiles to classic and novel ... 
      Alvarez, Eduardo; Sanhueza, Camila (Asociacion Espanola de Micologia, 2016)
      © 2016 Asociación Española de Micología Background Scedosporium species are considered emerging agents causing illness in immunocompromised patients. In Chile, only Scedosporium apiospermum, Scedosporium boydii and ...
    • Usefulness of serum galactomannan in initiating and modifying antifungal therapy in children with cancer ... 
      Delgado Araneda, Matías; Valenzuela Cortés, Romina; Maza León, Verónica de la; Rabello Gaitero, Marcela; Álvarez Neyra, Ana María; Contardo Pérez, María Verónica; Zubieta, Marcela; Gutiérrez, Valentina; Claverie, Ximena; Torres Torretti, Juan Pablo; Salgado Muñoz, Carmen; Tordecilla Cadiu, Juan; Varas Palma, Mónica; Avilés Lohmann, Carmen; Venegas F., Marcela; Villarroel Cickovic, Milena; Santolaya de Pablo, María Lorena (Wiley, 2020)
      Background Invasive fungal disease is a major cause of morbidity and mortality in children with cancer and high-risk febrile neutropenia (HRFN). Repeated serum galactomannan (sGM) measurements have been described as an ...